Legacy Financial Advisors, Inc. United Therapeutics Corp Transaction History

Legacy Financial Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$107.15 - $126.84 $29,573 - $35,007	-276 Closed	0 $0
Q4 2018 Jan 16, 2019	SELL	$101.4 - $128.73 $58,913 - $74,792	-581 Reduced 67.79%	276 $30,000
Q2 2018 Jul 17, 2018	SELL	$101.14 - $118.31 $24,273 - $28,394	-240 Reduced 21.88%	857 $107,000
Q1 2018 Apr 12, 2018	SELL	$107.21 - $151.94 $13,830 - $19,600	-129 Reduced 10.52%	1,097 $122,000
Q4 2017 Feb 09, 2018	BUY	$118.58 - $151.28 $145,379 - $185,469	1,226	1,226 $181,000

681

42.2M

194K

298K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Legacy Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Legacy Financial Advisors, Inc. with notifications on news.